. Author manuscript; available in PMC: 2021 Jan 1.

Published in final edited form as: Female Pelvic Med Reconstr Surg. 2020 Jan-Feb;26(1):37–43. doi: 10.1097/SPV.0000000000000592

Table 3.

Differences in symptom domains between groups

EPIQ^* Domain	Hispanic, n (%)	Non-Hispanic Caucasian, n (%)	Unadjusted OR (95% CI) Hispanic = reference group	Adjusted OR (95% CI) Hispanic = reference group
Pelvic organ prolapse	11 (7.14)	21 (5.04)	0.69 (0.32, 1.47) p=0.3337	N/A p=NA
Stress urinary incontinence	85 (55.19)	261 (62.59)	1.36 (0.93, 1.98) p=0.1091	1.60 (0.98, 2.63) p=0.0630
Overactive bladder	145 (94.16)	398 (95.22)	1.24 (0.55, 2.78) p=0.6089	N/A
Pain/voiding dysfunction	48 (31.17)	152 (36.45)	1.27 (0.85, 1.88) p=0.2408	1.44 (0.86, 2.39) p=0.1660
Anal incontinence	25 (16.34)	110 (26.38)	1.84 (1.13, 2.97) p=0.0134	1.61 (0.88, 2.95) p=0.1234
Defecating dysfunction	49 (31.82)	242 (58.03)	2.96 (2.00, 4.38) p<0.0001	2.37 (1.44, 3.92) p=0.0008

EPIQ=Epidemiology of Prolapse and Incontinence Questionnaire

^**

Adjusted for age, weight, height, estimated gestational age at time of questionnaire completion, education, and physical activity